Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

94 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mucocutaneous Leishmaniasis in a Pregnant Immigrant.
Briggs N, Wei BM, Ahuja C, Baker C, Foppiano Palacios C, Lee E, O'Grady N, Singanamala S, Singh K, Bandaranayake TD, Cohen JM, Damsky W, Davis MW, Mejia R, Nelson CA, Topal JE, Azar MM. Briggs N, et al. Open Forum Infect Dis. 2022 Jul 22;9(8):ofac360. doi: 10.1093/ofid/ofac360. eCollection 2022 Aug. Open Forum Infect Dis. 2022. PMID: 35928503 Free PMC article.
Pharmacotherapy of Chronic Neuropsychiatric Conditions During Pregnancy.
Westberg SM, Arellano R, Cieri-Hutcherson NE, Heinrich NT, Herman AM, Lodise NM, McBane S, Ofili TU, O'Grady N, Sankey KH. Westberg SM, et al. Among authors: o grady n. Nurs Womens Health. 2024 May 1:S1751-4851(24)00082-5. doi: 10.1016/j.nwh.2023.12.003. Online ahead of print. Nurs Womens Health. 2024. PMID: 38702041
SCCM/IDSA New Fever Guideline Correspondence Letter.
Deresinski SC, O'Grady N. Deresinski SC, et al. Among authors: o grady n. Clin Infect Dis. 2024 Mar 5:ciae118. doi: 10.1093/cid/ciae118. Online ahead of print. Clin Infect Dis. 2024. PMID: 38441985 No abstract available.
Impact of body mass index on pathological response after neoadjuvant chemotherapy: results from the I-SPY 2 trial.
Wang H, Yee D, Potter D, Jewett P, Yau C, Beckwith H, Watson A, O'Grady N, Wilson A, Brain S, Pohlmann P; I-SPY 2 Trial Consortium; Blaes A. Wang H, et al. Among authors: o grady n. Breast Cancer Res Treat. 2024 Apr;204(3):589-597. doi: 10.1007/s10549-023-07214-5. Epub 2024 Jan 12. Breast Cancer Res Treat. 2024. PMID: 38216819 Free PMC article.
Protein signaling and drug target activation signatures to guide therapy prioritization: Therapeutic resistance and sensitivity in the I-SPY 2 Trial.
Gallagher RI, Wulfkuhle J, Wolf DM, Brown-Swigart L, Yau C, O'Grady N, Basu A, Lu R, Campbell MJ, Magbanua MJ, Coppé JP; I-SPY 2 Investigators; Asare SM, Sit L, Matthews JB, Perlmutter J, Hylton N, Liu MC, Symmans WF, Rugo HS, Isaacs C, DeMichele AM, Yee D, Pohlmann PR, Hirst GL, Esserman LJ, van 't Veer LJ, Petricoin EF. Gallagher RI, et al. Among authors: o grady n. Cell Rep Med. 2023 Dec 19;4(12):101312. doi: 10.1016/j.xcrm.2023.101312. Epub 2023 Dec 11. Cell Rep Med. 2023. PMID: 38086377 Free PMC article.
94 results